Cell line modeling to study biomarker panel in prostate cancer. NickKholgh B, Fang X, Winters SM, Raina A, Pandya KS, Gyabaah K, Fino N, Balaji KC.. Prostate. 2016;76(3):245-258.
E-cadherin facilitates protein kinase D1 activation and subcellular localization. Li Z, Zhang C, Chen L, Li G, Qu L, Balaji KC, Du C.. J Cell Physiol. 2016;231(12):2741-2748.
Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Stuart CH, Singh R, Smith TL, D'Agostino R Jr, Caudell D, Balaji KC, Gmeiner WH.. Nanomedicine (Lond). 2016;11(10):1207-1222.
Secreted protein acidic and rich in cysteine (SPARC) mediates metastatic dormancy of prostate cancer in bone. Sharma S, Xing F, Liu Y, Wu K, Said N, Pochampally R, Shiozawa Y, Lin HK, Balaji KC, Watabe K.. J Biol Chem. 2016;291(37):19351-63.
Rapid bench to bed in management of metastatic prostate cancer [editorial]. Balaji KC.. Indian J Urol. 2016;32(4):255-256.
The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2. Gmeiner WH, Boyacioglu O, Stuart CH, Jennings-Gee J, Balaji KC.. Prostate. 2015;75(4):360-369.
Novel in vivo model for combinatorial fluorescence labeling in mouse prostate. Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC.. Prostate. 2015;75(9):988-1000.
Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience [editorial comment]. Balaji KC.. J Urol. 2015;193(6):1916-1917.
Differential expression of novel PKD1 related biomarker panel in African American men with prostate cancer [abstract]. Nickkholgh B, Fang XL, Winters SM, Fino N, Balaji KC.. Cancer Res. 2015;75(15 Suppl):4342.
Autophagy: friend or foe for progression and treatment of urothelial carcinoma [editorial]. Balaji KC.. J Urol. 2014;191(6):1644-1645.
Prorainbow: a novel in vivo prostate mouse model to track the origin of prostate cancer [abstract]. Wicks EE, Fang XL, Balaji KC.. Tissue Eng Part A. 2014;20(Suppl 1):S139-S140.
Biological basis of aggressive phenotype in African-American prostate cancer cell line [abstract]. Nickkholgh B, Fang XL, Gyabaah K, Balaji KC.. Cancer Res. 2014;74(19 Suppl):A4000.
Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK.. J Endourol. 2013;27(8):1046-1050.
Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC.. PLoS One. 2013;8(9):e75187.
Novel 3D co-cultural model for epithelial-stromal cells interaction in prostate cancer [abstract]. Fang XL, Sivanandane S, Gyabaah K Balaji KC.. Cancer Res. 2013;73(8 Suppl 1):A4078.
Metastatic potential of a renal mass according to original tumour size at presentation [editorial comment]. Balaji KC.. BJU Int. 2012;109(2):194.
Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network. Du C, Zhang C, Li Z, Biswas MHU, Balaji KC.. PLoS ONE. 2012;7(4):e33830.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Minimally Invasive Surgery, Urologic Oncology, Robotic Urologic Surgery, Laparoscopic Surgery
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
Dr.Balaji is one of my best doctors. I am a cancer survivor and put my life in his hands knowing that he will treat me well under any circumstances. Sometimes I have to wait in the treatment room longer than usual, but I understand because he is always taking enough time with other patients just as he never seemed rushed with me. I would wait an hour or more for him because he is a great and caring doctor. I give him a gold star. He is an true asset to Baptist Medical. By the way, in my previous visit I was an emotional wreck because of trial changes in my medications for depression. Dr. Balaji could not have been more understanding an patient. On this visit he asked about my mental health and took time to talk with me about depression. It was very comforting.
The Nurses and Dr. Balaji has the ability to make you feel like you are the only patient. VERY GOOD; Very Professional and Knowledgeable. I feel secure in trusting his judgment.
Dr. Balaji spent a good deal of time talking to me about my condition and explaining all my options for treatment and answering any and all questions I had.
Dr. Balaji is very empathetic and comforting. He explanation of a difficult situation gives me a sense of peace and encouragement. I feel lucky to have Dr. Balaji as one of my providers. I would definitely recommend Dr. Balaji to other patients, family and friends.
*Dr. Balaji is the best doctor I have ever had. He is professional and cares for his patients. I have complete confidence in his medical skills and advice. I hold deep respect for *Dr. Balaji. He is a man of great integrity!
Very good. #1. *Kethandapatti Balaji
outstanding service and doctor
A professional in discussing my situation.
A wonderful doctor.